CONTRATOS RIO HORTEGA 2019
Datos básicos
- Protocolo:
- CM19/00027
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- Año de finalización:
- 2022
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain
Article. 10.1111/eci.13771. 2022
Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes.
Ascaso, Pilar; (...); Real, Jose T
Article. 10.1111/ijcp.14302. 2021
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.
Palanca A; (...); Mathieu C
Article. 10.2337/dc21-1584. 2022
The Controversial Role of Vitamin D in Thyroid Cancer Prevention.
Palanca, A, Ampudia-Blasco, FJ, Real, JT
Article. 10.3390/nu14132593. 2022
Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
Ampudia-Blasco, F Javier; (...); Real, Jose T
Article. 10.1016/j.jdiacomp.2020.107828. 2021